Solid Dosage in europe

Cluster merger strengthens competitiveness

In 2020, Bosch Packaging Technology will reinvent itself. With the planned acquisition by CVC Capital, the processing and packaging technology division will be separated from the Bosch Group and will operate as a medium-sized enterprise. This fits in perfectly with a new and exciting market development: the planned merger of Packaging Valley e.V. (PV) and Packaging Excellence Region Stuttgart e.V. (PEC) into a large joint network. …more




Xelum R&D on world tour

Bosch Packaging Technology’s Xelum R&D for the continuous production of oral solid dosage (OSD) forms holds substantial potential: since it was first introduced to selected customers in 2018, the compact, innovative machine has attracted considerable interest. …more







Pharma Solid Knowledge Report: Automated Process Development (APD)

Quality by Design (QbD) was introduced by the American FDA in the ICH Q8 (R2) “as a new paradigm with significant effects on current and future trends in pharmaceutical development (2004).” QbD describes good practice for pharmaceutical product development and introduces concepts of design space and flexible regulatory aspects. It is a systematic approach to development, emphasizes product and process understanding, as well as process control.

To read Bosch’s mini white paper on this topic …more


Top of page